Group items tagged

Indswift today is a renowned name among lakhs of employees of railways, armed forces, police force & paramilitary organizations. With the help of our Institution division we are able to cater to smallest & biggest government dispensaries, hospitals and remote and rural areas in India.

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

This division of Ind Swift aspires to help those who cannot afford costly branded medicines. It is further divided into Agile, Maxcare and Health Care divisions which include a vast array of over 500 products from various therapeutic segments namely Antibiotic, Anti-Infectives, Anti-Cold, Nutraceuticals, Anti-Convulsants, Analgesics, Anti-Diarrhoeal, Anti-Allergics, Anti-Inflammatory and Anti-Ulcer Drugs, Hypolipidaemic Drugs, Anti Malarial, Enzyme, Expectorants, Antipsychotics & Anti-Depressants.

World Oral, Head and Neck Cancer Awareness Week 2015 is being observed from April 12 to April 18. Lt General Vimal Arora (Retd.), Chief Clinical Officer, Clove Dental (PVSM, AVSM and VSM) will answer your questions on these things at 4 PM, today. Post your questions.

Stress is very common disease of our day to day life, stress can affect both mental functions as well as immune system of our body.India herbs for stress relief and and relaxation are Ashwagandha, Giloy, Brahmi, Tulsi, Jatamansi,Shankhpushpi.

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

As of 2015, General Electric Company (U.S.) and Vital Images, Inc. (U.S.) [now part of Toshiba Corporation (Japan)] are estimated to hold the leadership position in the global market. Other key players in this market include Agfa-Gevaert N.V. (Belgium), Carestream Health, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Qi Imaging (U.S.), Siemens AG (Germany), TeraRecon, Inc. (U.S.), and Visage Imaging, Inc. (U.S.), among others. Market players primarily focus on the development of innovative AV software, geographic expansion, and strategic acquisitions as key strategies to ensure their growth in the advanced visualization market.

IBNLive Chat: India's relationship with oral hygiene & ban on chewing tobacco in Delhi -Lt General Vimal Arora (Retd)

Gefitinib Medicines, Erlotinib Tablets & Sorafenib Tosylate Exporter offered by Modern Times Helpline Pharma from New Delhi, Delhi, India

We, a young, dynamic and public-spirited team of activists at Happiness Ville, are constantly brainstorming ideas and ways to bring about the change we always talk about and hardly put into action. Our aim is to eradicate the 'mal' out of malnutrition, 'ill' out of the illiteracy, 'in' out of the injustice and the 'issues' out of the environment.